Valuation: Adocia

Market Cap 8.28Cr 9.44Cr 7.63Cr 7.14Cr 13Cr 890.43Cr 14Cr 92Cr 35Cr 440.07Cr 35Cr 35Cr 1.53TCr P/E 2026 *
15.9x
P/E 2027 * -9.78x
Enterprise Value 3.4Cr 3.88Cr 3.13Cr 2.93Cr 5.5Cr 365.78Cr 5.62Cr 38Cr 15Cr 180.78Cr 15Cr 14Cr 626.85Cr EV / Sales 2026 *
0.89x
EV / Sales 2027 * -0.59x
Free-Float
89.7%
Yield 2026 *
-
Yield 2027 * -
1 day+7.41%
1 week+2.12%
Current month-14.27%
1 month-14.96%
3 months-14.02%
6 months-33.49%
Current year-36.87%
1 week 3.87
Extreme 3.87
4.26
1 month 3.87
Extreme 3.87
5.13
Current year 3.87
Extreme 3.87
7.45
1 year 3.62
Extreme 3.62
12.4
3 years 2.86
Extreme 2.86
16.16
5 years 2.74
Extreme 2.745
16.16
10 years 2.74
Extreme 2.745
62.9
Manager TitleAgeSince
Chief Executive Officer 55 11/05/2023
Director of Finance/CFO - 23/09/2024
Chief Tech/Sci/R&D Officer - 01/12/2014
Director TitleAgeSince
Director/Board Member 55 19/04/2013
Chairman 80 24/02/2012
Director/Board Member 58 18/06/2013
Date Insider Type Main position Quantity % Market Cap.
27/25/27Buy

Founder

1,09,170 0.6972%
06/24/06Buy

Founder

15,576 0.1105%
06/24/06Buy

Founder

51,921 0.3685%
Change 5-day change 1-year change 3-year change Capi.($)
+7.41%+2.12%+15.10%+6.82% 8.77Cr
+0.33%+2.83%+62.37%+115.97% 5.53TCr
+0.82%+15.05%+74.28%+86.70% 5.19TCr
+1.36%+1.14%-14.06%-14.69% 2.28TCr
-1.04%+4.84%+1.61%+419.24% 2.26TCr
-0.18%+7.20%+28.56%-12.48% 1.74TCr
-1.10%+4.61%+29.38%-34.99% 1.61TCr
-3.35%+8.96%+135.18%+294.38% 1.4TCr
+2.89%+6.66%+27.11%+181.45% 1.34TCr
+1.31%+0.53%+27.21% - 1.23TCr
Average +0.85%+3.67%+38.67%+115.82% 2.26TCr
Weighted average by Cap. +0.25%+5.29%+46.85%+120.99%

Financials

2026 *2027 *
Net sales 3.84Cr 4.38Cr 3.54Cr 3.31Cr 6.21Cr 412.99Cr 6.34Cr 43Cr 16Cr 204.11Cr 16Cr 16Cr 707.77Cr 1.48Cr 1.68Cr 1.36Cr 1.27Cr 2.39Cr 158.7Cr 2.44Cr 16Cr 6.32Cr 78Cr 6.32Cr 6.18Cr 271.98Cr
Net income 39.76L 45.35L 36.65L 34.31L 64.34L 43Cr 65.68L 4.41Cr 1.7Cr 21Cr 1.7Cr 1.67Cr 73Cr -80.08L -91.34L -73.82L -69.11L -1.3Cr -86Cr -1.32Cr -8.87Cr -3.43Cr -43Cr -3.43Cr -3.35Cr -147.66Cr
Net Debt -4.88Cr -5.56Cr -4.5Cr -4.21Cr -7.89Cr -524.65Cr -8.06Cr -54Cr -21Cr -259.3Cr -21Cr -20Cr -899.12Cr -9.15Cr -10Cr -8.43Cr -7.89Cr -15Cr -984.11Cr -15Cr -101.34Cr -39Cr -486.37Cr -39Cr -38Cr -1.69TCr
Logo Adocia
Adocia is a biotechnology company that specializes in the development of innovative formulations of already-approved therapeutic proteins for the treatment of diabetes. At the end of 2025, the group had a portfolio of 4 products in clinical development (BioChaperone Lispro U100 and U200, BioChaperone Combo, M1Pram and BioChaperone Glucagon) and 4 preclinical-stage products (AdoShell® Islets, AdOral® Sema, AdoGel® Sema and BioChaperone® CagriSema).
Employees
73
Date Price Change Volume
26/26/26 4.230 +7.41% 1,36,263
25/26/25 €3.938 -1.60% 1,02,674
24/26/24 €4.002 -2.63% 69,952
23/26/23 €4.110 +0.24% 96,329
22/26/22 €4.100 -0.73% 1,06,018
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
3.938EUR
Average target price
13.00EUR
Spread / Average Target
+230.12%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ADOC Stock